Absci (ABSI) Current Leases (2020 - 2026)
Absci (ABSI) posted Current Leases of $1.9 million for Q1 2026, up 2.88% sequentially from $1.8 million in Q4 2025, and up 12.14% YoY from $1.7 million in Q1 2025.
Analysis
Absci (ABSI) Current Leases (2020 - 2026) Analysis & Trends
Absci has reported Current Leases for 7 years, with the latest figure at $1.9 million in Q1 2026.
- Quarterly Current Leases rose 12.14% year-over-year to $1.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.9 million (up 12.14% YoY) and the FY2025 annual result came in at $1.8 million, up 12.25% from the prior year.
- Current Leases rose to $1.9 million in Q1 2026 per ABSI's latest filing, from $1.8 million in the prior quarter.
- Over five years, Current Leases peaked at $2.8 million in Q1 2022 and troughed at $2000.0 in Q3 2025.
- A 5-year average of $1.6 million and a median of $1.7 million in 2025 frame the typical range for Current Leases.
- The widest YoY moves for Current Leases: up 682.11% in 2025, down 99.87% in 2025.
- Over 5 years, Current Leases stood at $2.3 million in 2022, then retreated by 26.87% to $1.7 million in 2023, then fell by 4.23% to $1.6 million in 2024, then grew by 12.25% to $1.8 million in 2025, then increased by 2.88% to $1.9 million in 2026.
- According to Business Quant data, Current Leases over the past three periods registered $1.9 million, $1.8 million, and $2000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 720.00 Mn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | 11.00 Mn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | 16.75 Mn |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 21.95 Mn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 45.93 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 6.27 Mn |
| 10 | Absci | 1.39 Bn | 1.19 Bn | - | 2.04 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2.04 Mn |
| Mar 31, 2026 | 1.86 Mn |
| Dec 31, 2025 | 1.81 Mn |
| Sep 30, 2025 | 1.75 Mn |
| Jun 30, 2025 | 1.71 Mn |
| Mar 31, 2025 | 1.66 Mn |
| Dec 31, 2024 | 1.61 Mn |
| Sep 30, 2024 | 1.57 Mn |
| Jun 30, 2024 | 1.61 Mn |
| Mar 31, 2024 | 1.59 Mn |
| Dec 31, 2023 | 1.68 Mn |
| Sep 30, 2023 | 1.75 Mn |
| Jun 30, 2023 | 1.73 Mn |
| Mar 31, 2023 | 2.03 Mn |
| Dec 31, 2022 | 2.30 Mn |
| Sep 30, 2022 | 2.51 Mn |
| Jun 30, 2022 | 2.65 Mn |
| Mar 31, 2022 | 2.77 Mn |
| Dec 31, 2021 | 2.79 Mn |
| Sep 30, 2021 | 2.77 Mn |